CEO of Invisalign Braces Maker Is Confident in China
*By Conor White*
With the company's first manufacturing plant in China up and running, the chief executive of Align Technology, the maker of Invisalign orthodontics, isn't concerned about a possible trade war between the United States and China.
"By the end of the year we'll have a good, contained business in China, and be able to service our Chinese business," said Joe Hogan, the CEO of Align Technology. "So I feel great about the moves we've made there, given the talks that are going on."
Align's stock was the top performer on the S&P 500 in the last year, soaring 132 percent in 2017. The company's management has said sales could top $2 billion by 2020.
To reach that goal, the company is reaching out directly to consumers who may need its Invisalign products: clear, plastic teeth aligners taking the place of traditional metal braces.
"We have a really strong consumer business, in the sense that we advertise to consumers, and direct them toward doctors," Hogan said in an interview Tuesday with Cheddar. "So the consumer awareness part of this is a big part of this strategy also."
Consumers are increasingly aware: Invisalign shipments are up more than 30 percent year-over-year in the first quarter of this year.
For the full interview, [click here](https://cheddar.com/videos/stars-align-for-invisalign).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
The original Birkin bag created by Hermès for Jane Birkin in 1984 is up for auction in Paris. Sotheby’s expects the iconic bag to sell for hundreds of thousands of euros on Thursday.
